Lamotte, Guillaume
Millar Vernetti, Patricio
Article History
First Online: 10 November 2021
Declarations
:
: Dr. Millar Vernetti was a site principal investigator of the Theravance-sponsored clinical trials; he received research funding from Theravance Biopharma. Dr. Lamotte has no conflicts.
Free to read: This content has been made available to all.